Consultant

Stephene Ford, BS, MBM

Stephene Ford has over 28 years of experience in the pharmaceutical industry, with specific expertise in the development of vaccines, infectious disease treatments, and biologic programs, including those up to BSL-2/3. She spent 17 years as a Study Director at CRL (Reno, NV, and Mattawan, MI), where she was responsible for the planning and conduct of nonclinical studies in accordance with applicable regulatory guidelines and contemporary scientific practices.

At the CRL Mattawan site, Stephene served as the subject matter expert for vaccines, building a robust vaccine program and providing clients with guidance and study designs for nonclinical IND-enabling programs. She also served as the chair of the Institutional Biosafety Committee and as the Biosafety Officer.

Prior to her time at CRL, she spent eight years at Covance Laboratories (now LabCorp) in Vienna, VA. As a consultant, previously for Aclairo Pharmaceutical Development Group, Inc., and currently at Akkeri, Stephene provides expertise in nonclinical assessments for the development of vaccines, biologics, and small molecules, as well as drugs for ocular, oncology, and infectious disease indications.

Stephene offers comprehensive toxicology program support, including study design, study monitoring, and regulatory support (such as data interpretation and presentation). She collaborates with multiple project teams and has experience in the preparation of government grants and regulatory submissions.